PHASE II EVALUATION OF THE COMBINATION OF TRIAZINATE, CYCLOPHOSPHAMIDE, DOXORUBICIN, AND CIS-DIAMMINEDICHLOROPLATINUM(II) IN PATIENTS WITH ADVANCED ADENOCARCINOMA OF THE LUNG

被引：0
作者：
EAGAN, RT
FRYTAK, S
INGLE, JN
CREAGAN, ET
NICHOLS, WC
KVOLS, LK
机构：
来源：
CANCER TREATMENT REPORTS | 1980年 / 64卷 / 8-9期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：925 / 928
页数：4
相关论文
共 8 条
[1]  
BRITELL JC, 1978, CANCER TREAT REP, V62, P1207
[2]  
EAGAN RT, 1979, CANCER TREAT REP, V63, P1589
[3]  
EAGAN RT, 1978, CANCER TREAT REP, V62, P843
[4]   VP-16, CYCLOPHOSPHAMIDE, ADRIAMYCIN AND CIS-PLATINUM (V-CAP-I) IN PATIENTS WITH METASTATIC ADENOCARCINOMA OF THE LUNG [J].
EAGAN, RT ;
CREAGAN, ET ;
INGLE, JN ;
RUBIN, J ;
FRYTAK, S ;
KVOLS, LK ;
FLEMING, TR .
TUMORI, 1979, 65 (01) :105-109
[5]  
EAGAN RT, 1979, CANCER, V44, P1125, DOI 10.1002/1097-0142(197909)44:3<1125::AID-CNCR2820440348>3.0.CO
[6]  
2-4
[7]  
EAGAN RT, 1977, CANCER TREAT REP, V61, P1339
[8]  
RODRIGUEZ V, 1977, CANCER RES, V37, P980
1